Chromatography

Cell Line Origin UK Caucasian Cell Line Description A B-lymphoblastoid cell line derived from a randomly selected Caucasian blood donor whose parents and grandparents were born in the UK or Ireland. The cell line was generated by Epstein-Barr Virus

Cell Line Origin UK Caucasian Cell Line Description A B-lymphoblastoid cell line derived from a randomly selected Caucasian blood donor whose parents and grandparents were born in the UK or Ireland. The cell line was generated by Epstein-Barr Virus

Cell Line Origin UK Caucasian Female Cell Line Description A B-lymphoblastoid cell line derived from a randomly selected Caucasian blood donor whose parents and grandparents were born in the UK or Ireland. The cell line was generated by

Cell Line Origin Human Amelanotic Melanoma Cell Line Description This cell line has been derived by the selection of the human amelanotic melanoma cell line C32 for 6-thioguanine resistance. The parent cell line C32 was established from a melanoma

Quantitative standard suitable for use as a retention index marker probe. Check out our complete portfolio of Fatty acid methyl ester (FAME) reference material solution mixes Application Refer to the product&#8242s Certificate of Analysis for more

Cell Line Origin Human Caucasian cervical carcinoma Cell Line Description From a cervical carcinoma of a 41 year old Caucasian female. Cells form spreading predominantly monolayered, epithelial colonies with hemicysts which are characteristic of

Application C75 has been used: as a fatty acid synthase (FASN) inhibitor to test its ability in the direct inhibition of FASN to attenuate mammosphere formation as compared to metformin as a pharmacological inhibitor to inhibit fatty acid synthesis

Application C75 has been used: as a fatty acid synthase (FASN) inhibitor to test its ability in the direct inhibition of FASN to attenuate mammosphere formation as compared to metformin as a pharmacological inhibitor to inhibit fatty acid synthesis

Cell Line Origin Human colorectal adenocarcinoma, moderately well differentiated, Dukes&#8242 stage D Cell Line Description The C75 cell line was established from a 56-year old male patient with a moderately well differentiated adenocarcnoma of

C8 COL 3UM L100 D2.1 EA

C8 COL 3UM L100 D4.6 EA

C8 COL 3UM L150 D2.1 EA